Vanda Pharmaceuticals (VNDA) Assets (2010 - 2026)

Vanda Pharmaceuticals (VNDA) has 17 years of Assets data on file, last reported at $433.5 million in Q1 2026.

• For the quarter ending Q1 2026, Assets fell 31.4% year-over-year to $433.5 million; the trailing twelve-month figure through Mar 2026 stood at $433.5 million (down 31.4% YoY), and the FY2025 full-year result was $488.9 million, down 25.49% from the prior year.
• Assets declined to $433.5 million in Q1 2026, from $488.9 million in the prior quarter.
• In the past five years, Assets ranged from a high of $656.2 million in Q4 2024 to a low of $433.5 million in Q1 2026.
• A 5-year average of $613.6 million and a median of $634.2 million in 2022 frame the typical range for Assets.
• Across the five-year window, Assets increased 11.11% in 2022 and slumped 31.4% in 2026, its largest moves.
• Tracing VNDA's Assets over 5 years: stood at $634.2 million in 2022, then gained by 2.24% to $648.4 million in 2023, then climbed by 1.2% to $656.2 million in 2024, then fell by 25.49% to $488.9 million in 2025, then decreased by 11.34% to $433.5 million in 2026.
• Business Quant data shows VNDA's Assets at $433.5 million in Q1 2026, $488.9 million in Q4 2025, and $601.1 million in Q3 2025.